Skip to main content
Embedded Service

Pharmacy Network Intelligence

Complete pharmacy access and coverage analysis

4,300 pharmacies mapped, classified, and linked to zone-level geographic intelligence. Chain identification, access grading, and coverage gap analysis for market planning.

What You Get

Pharmacy Classification

4,300 pharmacies mapped with chain identification, ownership type, and dispensing profile.

Access Grading

Zone-level pharmacy access scores based on density, distance, and operating hours.

Coverage Gap Analysis

Identify zones where pharmacy access is thin and alternative dispensing points matter.

Chain Network Mapping

Corporate chain footprint analysis across national and regional groups.

Dispensing Doctor Integration

Where pharmacies are sparse, dispensing doctors and clinics become the primary access point.

Market Entry Support

Network analysis for distribution planning, product launches, and territory coverage decisions.

The Map You Don’t Have

You know your customers. You know your sales. You probably know your market share.

But do you know the network?

The Blind Spot

How many pharmacies are in the zones where your sales are weakest? Are those zones underperforming because of weak rep activity, or because there are three pharmacies covering 80,000 people?

If you don’t know the answer, you are making territory decisions, distribution decisions, and investment decisions without seeing the infrastructure.


What 4,300 Pharmacies Tell You

We have mapped 4,300 pharmacies across South Africa. Each one classified, geolocated, and linked to its Her-Zone zone.

4,300
Pharmacies Mapped
Classified by chain, ownership, and geographic position
1,480
Zones
Each pharmacy linked to zone-level intelligence
44
Data Sources
Integrated into the geographic intelligence layer

This is not a pharmacy directory. It is a network analysis that answers commercial questions:

Where is pharmacy access strong?

Zones with high pharmacy density, multiple chains, and competitive dispensing infrastructure.

Where is pharmacy access thin?

Zones where a handful of pharmacies serve large populations. Where access depends on one or two outlets.

Where do dispensing doctors matter?

In zones with limited pharmacy infrastructure, dispensing doctors and clinics are the primary access point. Ignoring them means ignoring the market.

Which chains dominate which regions?

Corporate chain footprints vary dramatically by geography. National averages hide regional concentration.


Beyond the Pharmacy Layer

Pharmacy Network Intelligence is not just about pharmacies.

"

In many South African zones, the pharmacy is not the primary point of medicine access.

84% of the South African population accesses healthcare through the public sector. In zones where private pharmacy infrastructure is limited, dispensing doctors, public clinics, and hospitals become the dispensing network.

Example The Full Access Picture

A zone in rural Limpopo has two pharmacies serving a population of 120,000. But it also has 14 dispensing doctors and 6 public clinics.

If your distribution strategy only sees pharmacies, it misses 90% of the access infrastructure in that zone.

Our analysis integrates pharmacy data with dispensing doctor and clinic data to show the complete access picture. Your team decides how to plan around it.


Chain Network Analysis

Corporate pharmacy chains account for a significant share of dispensing volume. But their geographic footprints are not uniform.

National chains

Broad geographic coverage but concentrated in urban and peri-urban zones. Strong in high-income areas.

Regional groups

Concentrated footprints in specific provinces or regions. Often dominant locally despite smaller national presence.

Independent pharmacies

Scattered distribution. Often the only pharmacy in rural zones. Critical access points that national strategies overlook.

Distribution Strategy Starts Here

Which chains give you the broadest reach in your target zones? Where do independents matter more than chains? Where is the chain coverage so dense that differentiation, not distribution, is the challenge?

Pharmacy Network Intelligence answers these questions with data, not assumptions.


How We Work Together

1
Phase 1 1 week

Scope Definition

Define the geographic scope, the commercial questions, and how your data integrates with the pharmacy network analysis.

2
Phase 2 1-2 weeks

Network Mapping

Pharmacy classification, chain identification, and access grading across target zones. Integration with dispensing doctor and clinic data.

3
Phase 3 1 week

Gap Analysis

Coverage gap identification. Zones ranked by access quality. Distribution infrastructure mapped against your commercial footprint.

4
Phase 4 1 week

Delivery

Structured analysis with zone-level detail. Network maps. Chain coverage profiles. Actionable for distribution and territory planning.

Service Lead: Tiaan Keyser, Herbst Intelligence


What You Walk Away With

Pharmacy network map

4,300 pharmacies classified and linked to zone-level intelligence. Chain affiliation, ownership type, geographic position.

Access grade by zone

Every zone scored on pharmacy access quality. Density, distance to nearest pharmacy, chain presence.

Coverage gap report

Zones where pharmacy access is limited and alternative access points are critical. Quantified, not estimated.

Chain coverage profiles

Corporate chain footprint analysis. Regional dominance patterns. Distribution reach by group.

Full access layer

Pharmacies, dispensing doctors, clinics. The complete picture of where medicines reach patients in your target geography.


Data Transparency

We are transparent about what the data covers and where it does not.

What We Know and What We Don't

The pharmacy dataset covers 4,300 pharmacies. South Africa has an estimated 4,000+ registered retail pharmacies. Coverage is strong in urban and peri-urban areas. Rural coverage depends on available source data.

We do not claim completeness. We document what the data includes, where gaps exist, and what additional sources could improve coverage.

We adhere to data provider restrictions in line with the ISO 27001 standards we are actively pursuing. Pharmacy data sources are documented and auditable. Your commercial data stays in your engagement.


The Infrastructure Question

"

Before you ask “why aren’t we selling more here?” ask “can patients access medicine here at all?”

Pharmacy Network Intelligence answers the infrastructure question. It shows where the dispensing network supports your commercial strategy and where infrastructure gaps limit what any field force can achieve.

The Network, Visible

4,300 pharmacies. Dispensing doctors. Public clinics. Chain coverage. Access grades.

The infrastructure your strategy depends on, mapped and quantified. Your team decides what to do with it.

Frequently Asked Questions

What is Pharmacy Network Intelligence?

Pharmacy Network Intelligence provides a complete picture of pharmacy access across South Africa. We have mapped 4,300 pharmacies with classification data including chain affiliation, ownership type, and geographic position. This is integrated with Her-Zone zone-level intelligence to produce access grades, coverage gaps, and network analysis.

Where does the pharmacy data come from?

Pharmacy location and classification data comes from multiple sources including pharmacy location databases, corporate chain registries, and open geographic data. We do not use syndicated data provider databases for this analysis. All sources are documented and auditable.

How current is the data?

Pharmacy data is updated as new sources become available. The current dataset covers 4,300 pharmacies. Coverage varies by region. We are transparent about what the data includes and where gaps exist.

Can you identify which pharmacies stock specific products?

Not directly from our data. Pharmacy Network Intelligence maps the network itself. Product-level stocking data comes from your commercial data or syndicated sources. We integrate the two to show where your products are available and where the network has gaps.

What about areas with no pharmacies?

This is where the analysis is most valuable. In zones with limited pharmacy access, dispensing doctors and public clinics become the primary dispensing points. Our analysis includes these alternative access points so you see the full picture, not just the pharmacy layer.

How does this support market entry planning?

If you are launching a product or entering a new therapeutic area, Pharmacy Network Intelligence shows you where dispensing infrastructure exists, which chains have the strongest regional coverage, and where distribution gaps might limit your reach. Your team uses this to plan distribution strategy.

Ready to Transform Your Commercial Operations?

Let's discuss how Pharmacy Network Intelligence can deliver measurable outcomes for your business.

Start a Conversation